IGA NEPHROPATHY (IGAN)
Clinical trials for IGA NEPHROPATHY (IGAN) explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY (IGAN) trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ancient herbal formula tested in modern fight against kidney disease
Disease control Not yet recruitingThis study aims to find out if a traditional Chinese herbal formula called Shenqi Yishen Granules can help treat IgA nephropathy, a type of kidney disease. Researchers will enroll 102 adults with early-stage disease to see if the granules reduce protein in their urine better than…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: NA • Sponsor: Keda Lu • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First human tests begin for new kidney disease treatment
Knowledge-focused Not yet recruitingThis is an early safety study for a new injection called RG002C0106, which is being developed for IgA Nephropathy, a type of kidney disease. Researchers want to see how the drug behaves in the body and if it is safe in 24 healthy adults and adults with mild-to-moderate kidney pro…
Matched conditions: IGA NEPHROPATHY (IGAN)
Phase: PHASE1 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC